| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $800K | — | -77.1% |
| R&D Expense | $15.6M | +286.5% | +128.2% |
| SG&A Expense | $11.0M | +149.9% | +131.0% |
| Operating Income | -$26.6M | -203.9% | -114.3% |
| Pre-tax Income | -$24.9M | -803.1% | -143.1% |
| Income Tax | -$74K | -593.3% | -840.0% |
| Net Income | -$24.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $103.2M | +77.0% | +128.3% |
| Short-term Investments | $39.4M | +5.5% | -57.5% |
| Current Assets | $147.5M | +49.0% | +4.2% |
| Total Assets | $160.9M | +27.5% | +8.0% |
| Current Liabilities | $11.1M | +52.2% | +20.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$40.6M | — | — |
| Investing Cash Flow | -$4.5M | — | — |
| Financing Cash Flow | $135.5M | — | — |
| -795.5% |
| -142.1% |
| EPS (Basic) | -$2.91 | -4750.0% | -1285.7% |
| EPS (Diluted) | -$2.91 | -4750.0% | -1285.7% |
| $21.0M |
| +105.1% |
| +42.6% |
| Stockholders' Equity | $139.8M | +20.6% | +4.2% |